Log In
BCIQ
Print this Print this
 

Generic thrice-weekly glatiramer acetate

  Manage Alerts
Collapse Summary General Information
Company Synthon B.V.
DescriptionGeneric version of thrice-weekly Copaxone glatiramer acetate, a selective major histocompatibility complex (MHCII) class II modulator
Molecular Target Major histocompatibility complex class II (MHCII)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentApproved
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today